Goldman Sachs’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.77M Buy
200,001
+179,914
+896% +$4.34M ﹤0.01% 3743
2025
Q4
$486K Sell
20,087
-41,457
-67% -$1M ﹤0.01% 5604
2025
Q3
$1.49M Buy
61,544
+49,000
+391% +$1.18M ﹤0.01% 4731
2025
Q2
$301K Buy
+12,544
New +$297K ﹤0.01% 5443
2024
Q4
Sell
-20,809
Closed -$501K 6142
2024
Q3
$501K Buy
+20,809
New +$496K ﹤0.01% 5049
2022
Q4
Sell
-52,447
Closed -$1.19M 6120
2022
Q3
$1.19M Buy
+52,447
New +$1.23M ﹤0.01% 4390

Other funds holding IBD

Goldman Sachs's IBD Position: Q1 2026 in Review

Goldman Sachs increased its Inspire Corporate Bond ETF (IBD) stake by 896% in Q1 2026, buying an estimated $4.34M and bringing the position to 200,001 shares worth $4.77M. The position accounts for ﹤0.01% of the portfolio, ranked #3743.

Goldman Sachs first reported a position in IBD in Q3 2022 and has held it in 6 quarters since. 106 funds tracked by Wall St. Rank hold IBD as of Q1 2026.

  • Goldman Sachs held 200,001 shares of Inspire Corporate Bond ETF worth $4.77M as of Q1 2026.
  • Goldman Sachs bought 179,914 Inspire Corporate Bond ETF shares in Q1 2026, an estimated $4.34M.
  • Inspire Corporate Bond ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3743 holding.
  • Goldman Sachs first reported a position in Inspire Corporate Bond ETF in Q3 2022 and has held it in 6 quarters since.
  • 106 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.